Structure of Ponatinib
CAS No.: 943319-70-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50 values of 0.37 nM for Abl, 1.1 nM for PDGFRα, 1.5 nM for VEGFR2, 2.2 nM for FGFR1, and 5.4 nM for Src.
Synonyms: AP24534
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Leclercq, Gabrielle ;
Abstract: T cell bispecific antibodies (TCBs) are a novel class of T cell engagers redirecting T cells towards tumor cells, facilitating the formation of a cytotoxic synapse and resulting in tumor celllysis. On-target activity of TCBs may come with a risk of Cytokine Release Syndrome (CRS), characterized by elevated levels of pro-inflammatory cytokines in the serum, such as IL-6, IL-1β, TNF-α or IFN-γ and over activation of immune cells. Besides, the expression of the tumorassociated antigen on healthy cells may induce off-tumor activity of the TCB and contribute to inflammation. Despite the use of step-up dosing, glucocorticoids, or tocilizumab to manage or prevent these safety liabilities, they remain the major dose-limiting toxicities associated with the treatment of T cell engagers, highlighting the need to develop preventive mitigation treatments. To this aim, we investigated the biological mechanisms and the chronology of events involved in TCB-mediated cytokine release and explored mitigation strategies that might retain profound treatment efficacy while reducing cytokine release. Using an in vitro co-culture of peripheral blood mononuclear cells (PBMCs) or total leukocytes(PBMCs + neutrophils) and target cells with the respective TCBs, or whole blood treated with a B cell depleting TCB, we confirmed the contribution of T cell and myeloid cells and revealed the role of neutrophils in the TCB-mediated cytokine release. In the same model, the use of anticytokine neutralizing antibodies provided insights into the chronology of events triggering the cascade of cytokines after TCB stimulation. Ultimately this work guided the evaluation of mitigation strategies directed against T-cell derived cytokine release by targeting kinases involved in signaling pathways downstream of the T cell receptor (TCR) after stimulation with TCBs. A novel small molecule-kinase inhibitors screen identified mTOR, JAK and Src inhibitors as candidates to switch-off T-cell derived cytokine release. We validated the effects of these kinase inhibitors and fine-tuned their effective doses in in vitro co-cultures of peripheral blood mononuclear cells (PBMCs) and tumor cells with the respective TCBs. In vivo, we used nontumor or tumor-bearing-humanized NSG mice to assess the effect of mTOR, JAK and Srcinhibitors on CD19-TCB-mediated cytokine release and anti-tumor efficacy. Altogether, we confirmed the biological mechanisms of the TCB-mediated cytokine cascade and revealed the contribution of neutrophils. Our work on kinase inhibitors highlights their differential activities on the inhibition of cytokine release and/or T cell cytotoxicity and demonstrates the decoupling between both mechanisms. Our data open new horizons for the prophylactic mitigation of CRS with the use of FDA approved mTOR and JAK inhibitors or the transient use of the Src inhibitor dasatinib. Finally, our results also indicate that dasatinib may serve as an “antidote” against adverse events related to the treatment with TCBs such as high grade CRS or unpredictable off-tumor activity of TCBs, a strategy which is now implemented the clinic.
Show More >
Purchased from AmBeed: 302962-49-8 ; 943319-70-8 ; 162635-04-3 ; 53123-88-9 ; 380843-75-4
Show More >
CAS No. : | 943319-70-8 |
Formula : | C29H27F3N6O |
M.W : | 532.56 |
SMILES Code : | O=C(NC1=CC=C(CN2CCN(C)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(C#CC4=CN=C5C=CC=NN54)=C3 |
Synonyms : |
AP24534
|
MDL No. : | MFCD17215203 |
InChI Key : | PHXJVRSECIGDHY-UHFFFAOYSA-N |
Pubchem ID : | 24826799 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H320-H335 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
human mesenchymal stromal cells (hMSCs) | 25 ng/ml | 20 min | To study the inhibitory effect of Ponatinib on MEKK2 phosphorylation, results showed that Ponatinib significantly reduced MEKK2 phosphorylation levels. | PMC7658220 |
Saos-2 cells | 1 µM | 1 h | To study the inhibitory effect of Ponatinib on ERK1/2 phosphorylation, results showed that Ponatinib completely inhibited FGF2-induced ERK activation. | PMC7658220 |
MDA-MB-231 cells | 1 μM | 24 h | Inhibited cell migration and mammosphere formation | PMC6338618 |
LM2 cells | 1 μM | 24 h | Inhibited cell migration and mammosphere formation | PMC6338618 |
BaF3 cells | < 50 nM | Ponatinib effectively inhibits phosphoactivation of the fusion kinases and their downstream effectors, such as PLCγ, Stat5 and Src | PMC3629706 | |
KG1 cells | < 50 nM | Ponatinib effectively inhibits phosphoactivation of the fusion kinases and their downstream effectors, such as PLCγ, Stat5 and Src | PMC3629706 | |
human CD34+ progenitor cells | 50 nM | 48 h | Ponatinib significantly inhibits cell growth and clonogenicity | PMC3629706 |
lung cancer cell lines | 0 – 300 nM | 14 days | To evaluate the effect of Ponatinib on the growth of lung cancer cell lines, 14/58 cell lines were sensitive to Ponatinib (IC50 ≤ 50 nM), and sensitivity correlated with FGFR1 mRNA and protein expression. | PMC4062100 |
LPS141 | 250-1000 nM | 16 h | Ponatinib inhibited the KIT signaling pathway and clonogenic proliferation in LPS141 and MLS402 cells. | PMC5683536 |
MLS402 | 250-1000 nM | 16 h | Ponatinib inhibited the KIT signaling pathway and clonogenic proliferation in LPS141 and MLS402 cells. | PMC5683536 |
MDA-MB-231 cells | 1 μM | 24 h | Ponatinib significantly inhibited the migration and mammosphere formation of MDA-MB-231 cells. | PMC6338618 |
LM2 cells | 1 μM | 24 h | Ponatinib significantly inhibited the migration and mammosphere formation of LM2 cells. | PMC6338618 |
GIST T1 cells | 0.021 ± 0.000 μM | 72 h | To evaluate the antiproliferative activity of Ponatinib in GIST T1 cells, the results showed an IC50 value of 0.021 ± 0.000 μM, similar to the activity of HQP1351 and imatinib. | PMC6815454 |
GIST 430 cells | 0.134 ± 0.057 μM | 72 h | To evaluate the antiproliferative activity of Ponatinib in GIST 430 cells, the results showed an IC50 value of 0.134 ± 0.057 μM, slightly weaker than HQP1351. | PMC6815454 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
mice | acute kidney injury models (AKI) | intraperitoneal injection | 15 mg/kg | administered 6 hours before the induction of ischemia | Ponatinib significantly alleviated acute kidney injury in mice, as evidenced by reduced serum creatinine and BUN, as well as attenuated morphologic injury and cell death. | PMC7893143 |
mice | Nf1fl/fl;Dmp1-Cre mice | intraperitoneal | 25 mg/kg | daily for 5 weeks | To study the ameliorative effect of Ponatinib on NF1-associated skeletal pathology, results showed that Ponatinib significantly improved skeletal defects in Nf1fl/fl;Dmp1-Cre mice. | PMC7658220 |
BALB/c-nude mice | breast cancer lung metastasis (BCLM) model | oral gavage | 30 mg/kg | once daily for 30 days | Ponatinib significantly inhibited breast cancer lung metastasis | PMC6338618 |
mice | SCLL cell transplantation model | oral | 30 mg/kg | daily, duration not specified | Ponatinib significantly delays or even prevents tumorigenesis of KG1 cells in xenotransplanted mice | PMC3629706 |
NOD SCID gamma mice | Xenograft model | Oral | 10 mg/kg | Daily for 3 weeks | Ponatinib significantly inhibited the growth of liposarcoma in the xenograft model, reduced tumor cell proliferation, and induced apoptosis. | PMC5683536 |
BALB/c-nude mice | breast cancer lung metastasis (BCLM) model | oral gavage | 30 mg/kg | daily for up to 30 consecutive days | Ponatinib significantly inhibited breast cancer lung metastasis, reducing more than 90% of cancer cell colonization in the lung. | PMC6338618 |
Mice | GIST T1 and GIST 430 xenograft models | Oral | 40 mg/kg | Once weekly for 3 weeks | To evaluate the antitumor activity of Ponatinib in GIST T1 and GIST 430 xenograft models, the results showed that the antitumor activity of Ponatinib at 40 mg/kg was slightly weaker than HQP1351. | PMC6815454 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02551718 | Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << | Not Applicable | Recruiting | - | United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker Less << |
NCT01883219 | Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Stem Cell Transplantation Minimal Residual Disease Less << | Phase 2 | Unknown | November 2017 | China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin, MD +86-020-61641613 lansinglinren@hotmail.com Less << |
NCT03331211 | - | Recruiting | September 1, 2019 | China, Guangdong ... More >> Department of Hematology,Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Xutao Guo 008613802426709 ext 1 gxt827@126.com Less << | |
NCT03624530 | Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Tyrosine Kinase Inhibitor Minimal Residual Disease Allogeneic Hematopoietic Stem Cell Transplantation Less << | Phase 2 Phase 3 | Recruiting | July 2022 | China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-62787883 356135708@qq.com Principal Investigator: Qifa Liu Less << |
NCT03746054 | Chronic Myeloid Leukemia (CML) | Phase 3 | Not yet recruiting | March 2023 | - |
NCT02779283 | Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << | Phase 1 | Recruiting | June 1, 2019 | United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon 503-494-8950 spurgeos@ohsu.edu Principal Investigator: Stephen E. Spurgeon Less << |
NCT02455024 | - | Recruiting | September 30, 2021 | United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack UMC (Site 128) Recruiting Hackensack, New Jersey, United States, 07601 Principal Investigator: Stefan Faderl, MD United States, New York Hudson Valley Hematology Oncology Associates (Site 236) Recruiting Hawthorne, New York, United States, 10532 Principal Investigator: Karen Seiter, M.D. Less << | |
NCT02448095 | Chronic Myeloid Leukemia|Phila... More >>delphia Positive Less << | TERMINATED | 2018-07-17 | UO Ematologia con trapianto-Un... More >>iversità degli Studi di Bari Aldo Moro, Bari, Italy|IRCCS_AOU San Martino-IST.Clinica Ematologica, Genova, Italy|ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy|Azienda Ospedaliera "S.Gerardo", Monza, Italy|S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy|Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 - Orbassano, Orbassano, Italy|S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy|Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|U.O.C. Ematologia - Ospedale S. Eugenio, Roma, Italy Less << | |
NCT03515785 | - | Withdrawn(Revisiting the avail... More >>ability of patients with Ph+ ALL that would meet the in-/exclusion criteria of the study led to the decision not to move forward.) Less << | March 2021 | Czechia ... More >> Ihbt/Úhkt Praha, Czechia, 128 00 France University Hospital Amiens Amiens, France, 80080 University Hospital Angers Angers, France, 49100 University Hospital Bordeaux Bordeaux, France, 33000 University Hospital Grenoble Grenoble, France, 38700 University Hospital Lyon Lyon, France, 69361 University Cancer Institute Oncopole Toulouse, France, 31059 Germany University Hospital Halle/Saale Halle/Saale, Germany, 06120 University Hospital Munich Munich, Germany, 81377 University Hospital Rostock Rostock, Germany, 18057 Less << | |
NCT02767063 | Leukemia, Myeloid, Chronic-Pha... More >>se Less << | Phase 1 Phase 2 | Recruiting | June 2021 | France ... More >> Martine GARDEMBAS Recruiting Angers, France Contact: Martine GARDEMBAS 02.41.35.44.75 MaGardembas@chu-angers.fr Pascale CONY.MAKHOUL Recruiting Annecy, France Contact: Pascale CONY.MAKHOUL 04.50.63.64.31 pconymakhoul@ch-annecygenevois.fr Thorsten BRAUN Recruiting Bobigny, France Contact: Thorsten BRAUN 01.48.95.54.58 Thorsten.braun@avc.aphp.fr Etienne Recruiting Bordeaux, France Contact: Gabriel Etienne 05.56.33.04.76 G.Etienne@bordeaux.unicancer.fr CHU Côte de Nacre Not yet recruiting Caen, France Contact: Hyacynthe Johnson-Ansah 02.31.27.25.39 Johnsonansah-a@chu-caen.fr CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Marc BERGER mberger@chu-clermontferrand.fr CH Henri Mondor Recruiting Créteil, France Contact: ROY Lydia Rousselot Recruiting Le Chesnay, France Contact: Philippe Rousselot 01.39.63.89.09 phrousselot@ch-versailles.fr CHU Lille Recruiting Lille, France Contact: COITEUX Valérie CHU de LIMOGES Not yet recruiting Limoges, France Contact: Amélie PENOT 05.55.05.66.42 Amelie.penot@chu-limoges.fr Franck NICOLINI Recruiting Lyon, France Contact: Franck NICOLINI 04.72.11.74.01 franck.nicolini@chu-lyon.fr Institut P Calmette Recruiting Marseille, France Contact: CHARBONNIER Aude Viviane DUBRUILLE Recruiting Nantes, France Contact: Viviane DUBRUILLE 02.40.08.32.71 Viviane.dubruille@chu-nantes.fr Hopital l'Archet Not yet recruiting Nice, France Contact: Laurence LEGROS 04.92.03.58.41 legros.l@chu-nice.fr Eric JOURDAN Recruiting Nimes, France Contact: Eric JOURDAN 04.66.68.32.31 eric.jourdan@chu-nimes.fr Hôpital La Source Recruiting Orléans, France Contact: BENBRAHIM Omar Delphine REA _St louis Recruiting Paris, France Contact: Delphine REA 01.42.49.96.49 delphine.rea@aphp.fr Simona LAPUSAN_St Antoine Recruiting Paris, France Contact: Simona LAPUSAN 01.49.28.34.42 Simona.lapusan@sat.aphp.fr Cayssials Recruiting Poitiers, France Contact: Emilie Cayssials : 05.49.44. 44.72 e.cayssials@chu-poitiers.fr CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: ESCOFFRE-BARBE Martine Hôpital René Huguenin Not yet recruiting Saint-Cloud, France Contact: Sylvie GLAISNER 01.47.11.15.30 Sylvie.glaisner@curie.net Institut Universitaire contre le Cancer Not yet recruiting Toulouse, France Contact: Françoise HUGUET 05.31.15.63.56 Huguet.françoise@iuct-oncopole.fr CHU Tours Not yet recruiting Tours, France Contact: DARTIGEAS Caroline Less << |
NCT03263572 | Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Acute Lymphoblastic Leukemia Less << | Phase 2 | Recruiting | November 2023 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact ejabbour@mdanderson.org Less << |
NCT01620216 | Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << | Phase 2 | Recruiting | March 30, 2019 | United States, Maryland ... More >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan 301-803-8029 hourigan@nih.gov Principal Investigator: Christopher S. Hourigan United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux 503-494-9383 loriauxm@ohsu.edu Principal Investigator: Marc Loriaux United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins 214-648-4155 robert.collins@utsouthwestern.edu Principal Investigator: Robert H. Collins United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics 801-585-3229 tibor.kovacsovics@hci.utah.edu Principal Investigator: Tibor J. Kovacsovics Less << |
NCT03576547 | Blast Phase Chronic Myelogenou... More >>s Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Lymphoblastic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive t(9;22) Less << | Phase 1 Phase 2 | Recruiting | January 31, 2019 | United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Farhad Ravandi-Kashani 713-745-0394 Principal Investigator: Farhad Ravandi-Kashani Less << |
NCT03147612 | Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia With BCR-ABL1 Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << | Phase 2 | Recruiting | February 8, 2024 | United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour 713-792-4764 Principal Investigator: Elias Jabbour Less << |
NCT01424982 | Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Less << | Phase 2 | Recruiting | October 31, 2021 | United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour 713-792-7026 Principal Investigator: Elias Jabbour Less << |
NCT03678454 | - | Recruiting | November 30, 2019 | Belgium ... More >> ZNA Stuyvenberg Recruiting Antwerpen, Belgium, 2060 UZ Antwerpen Recruiting Antwerpen, Belgium, 2650 AZ Klina Recruiting Brasschaat, Belgium, 2930 AZ St-Jan Brugge Recruiting Brugge, Belgium, 8000 Institut Jules Bordet Recruiting Brussels, Belgium, 1000 CHU Brugmann Recruiting Brussels, Belgium, 1020 Hopital Erasme Recruiting Brussels, Belgium, 1070 UZ Brussel Recruiting Brussels, Belgium, 1090 Clinique universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Ziekenhuis Oost Limburg (ZOL) Recruiting Gent, Belgium, 3600 Hopital Jolimont Recruiting Haine-Saint-Paul, Belgium, 7100 Jessa Ziekenhuis Recruiting Hasselt, Belgium, 3500 AZ Groeninge Recruiting Kortrijk, Belgium, 8500 UZ Leuven Recruiting Leuven, Belgium, 3000 CHU Sart Tilman Liège Recruiting Liège, Belgium, 4000 CHU Charleroi Vésale Recruiting Montigny-le-Tilleul, Belgium, 6110 AZ Turnhout St-Elisabeth Recruiting Turnhout, Belgium, 2300 CHR La Tourelle Recruiting Verviers, Belgium, 4800 CHU/UCL Namur Mont-Godinne Recruiting Yvoir, Belgium, 5530 Less << | |
NCT02776605 | ALL | Phase 2 | Recruiting | December 2020 | Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Josep Mª Ribera, Dr jribera@iconcologia.net Hospital Clinic Recruiting Barcelona, Spain, 08036 Contact: Jordi Esteve, Dr JESTEVE@clinic.ub.es Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain Contact: Pere Barba, Dr pebarba@vhebron.net Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Mª Pilar Martinez Sánchez, Dr mpmartinezs.hdoc@salud.madrid.org Hospital Virgen de la Victoria Recruiting Málaga, Spain Contact: Mª José Moreno, Dr mjmorenorico@hotmail.com Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Jesús Maria Hernández Rivas, Dr jmhr@usal.es Hospital Marques de Valdecilla Recruiting Santander, Spain Contact: Mª Aranzazu Bermudez, Dr mbermudez@humv.es C H Santiago de Compostela Recruiting Santiago de Compostela, Spain Contact: Natalia Alonso, Dr natalia.alonso.vence@sergas.es Hospital Virgen del Rocio Recruiting Sevilla, Spain Contact: Jose Gonzalez Campos, Dr jose.gonzalez.sspa@juntadeandalucia.es Hospital Clinico de Valencia Recruiting Valencia, Spain Contact: Mª del Mar Tormo, Dr tormo_mar@gva.es Hospital La Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr montesinos_pau@gva.es Less << |
NCT03704688 | Non Small Cell Lung Cancer ... More >> KRAS Gene Mutation Less << | Phase 1 Phase 2 | Recruiting | April 2021 | United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Kathryn Arbour, MD 646-449-1775 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Kathryn Arbour, MD 646-449-1775 Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Kathryn Arbour, MD 646-449-1775 Memorial Sloan Kettering @ Rockville Recruiting Rockville Centre, New York, United States, 11570 Contact: Kathryn Arbour, MD 646-449-1775 Less << |
NCT00660920 | Chronic Myelogenous Leukemia|H... More >>ematologic Malignancies Less << | PHASE1 | COMPLETED | 2025-05-16 | ARIAD Investigational Site #07... More >>5, San Francisco, California, 94143, United States|ARIAD Investigational Site #011, Ann Arbor, Michigan, 48109, United States|ARIAD Investigational Site #048, Portland, Oregon, 97239, United States|ARIAD Investigational Site #076, Nashville, Tennessee, 37203, United States|ARIAD Investigational Site #005, Houston, Texas, 70030, United States Less << |
NCT01746836 | Chronic Phase Chronic Myelogen... More >>ous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Less << | Phase 2 | Active, not recruiting | January 31, 2019 | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT01838642 | Thyroid Neoplasms | PHASE2 | TERMINATED | 2025-01-16 | National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less << |
NCT01650805 | - | Terminated(Study terminated ba... More >>sed on evaluation of safety data.) Less << | - | - | |
NCT01838642 | Thyroid Neoplasms | PHASE2 | TERMINATED | 2025-01-16 | National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less << |
NCT01207440 | Chronic Myeloid Leukemia|Ph+ A... More >>cute Lymphoblastic Leukemia Less << | PHASE2 | COMPLETED | 2019-01-17 | Royal North Shore Hospital, St... More >> Leonards, New South Wales, 2065, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Alfred Hospital, Box Hill, Victoria, 3128, Australia|Peter MacCallum Cancer Centre, East Melbourne, Victoria, 3002, Australia|UCL Bruxelles, Bruxelles, 1200, Belgium|UZ Leuven, Leuven, 3000, Belgium|Institut Bergonie, Bordeaux, 33076, France|Hopital Andre Mignot, Le Chesnay, 78157, France|Hopital Claude Huriez CHRU, Lille, 59307, France|Chu Brabois, Nancy, 54551, France|Hopital Archet, Nice, 6202, France|Hopital St. Louis, Paris, 75010, France|Hopital Edouard Herriot, Pierre-Benite, 69495, France|Entre Hospitalier Universitaire, Poitiers, 86021, France|Hopital de Purpan, Toulouse, 31059, France|Charite - Universitatsmedizin Berlin,, Berlin, 13353, Germany|Klinikum der Goethe Universitat,, Frankfurt, 60590, Germany|Universitatsklinikum Jena, Jena, 07747, Germany|University of Heidelberg, Mannheim, 68169, Germany|III. Med. Klinik und Poliklinik, Munchen, 81675, Germany|Universita di Bologna, Bologna, 40138, Italy|University of Modena, Modena, 41124, Italy|University of Milano Bicocca, Monza, 20052, Italy|University of Turin, Orbassano (TO), 10043, Italy|University Tor Vergata, Roma, 144, Italy|The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul, 137-701, Korea, Republic of|VU University Medical Center, Amsterdam, 1081 HV, Netherlands|University Medical Center Groeningen, Groningen, 9713 GZ, Netherlands|Singapore General Hospital, Singapore, 169608, Singapore|Hospital Clinic, Barcelona, 8036, Spain|La Paz, Madrid, 28046, Spain|Hospital Universitario de Salamanca, Salamanca, 37007, Spain|Hospital Clinico of Valencia, Valencia, 46010, Spain|Lund University, Lund, 22185, Sweden|Karolinska Hospital, Stockholm, 17176, Sweden|University Hospital Uppsala, Uppsala, 75185, Sweden|Gartnavel General Hospital, Glasgow, G12 0XB, United Kingdom|Royal Liverpool University Hospital, Liverpool, L7 8XP, United Kingdom|Hammersmith Hospital, London, W12 0NN, United Kingdom|Royal Victoria Infirmary, Newcastle, NE2 4HH, United Kingdom|University of Nottingham, Nottingham, NG5 1PB, United Kingdom Less << |
NCT01549548 | Philadelphia Chromosome Positi... More >>ve (Ph+) Leukemias|Chronic Myeloid Leukemia Less << | NO_LONGER_AVAILABLE | - | OHSU Knight Cancer Institute, ... More >>Portland, Oregon, 97239, United States Less << | |
NCT01641107 | Philadelphia Positive|BCR-ABL ... More >>Positive|Acute Lymphoblastic Leukemia Less << | PHASE2 | COMPLETED | 2021-09-30 | S.O.C. di Ematologia - Azienda... More >> Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI, Ancona, Italy|Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni", Ascoli, Italy|Az.Ospedaliera S.G.Moscati, Avellino, Italy|Azienda Ospedaliera - Papa Giovanni XXIII, Bergamo, Italy|Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy|ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy|Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy|Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Ferrara, Italy|Policlinico di Careggi, Firenze, Italy|Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino", Genova, Italy|ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy|Unità Operativa Complessa - Medicina Generale - Sezione di Ematologia - Ospedale Versilia USL 12 Toscana, Lido di Camaiore, Italy|Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST, Meldola, Italy|U.O. di Ematologia- Ospedale dell'Angelo - Mestre, Mestre, Italy|Ospedale Niguarda " Ca Granda", Milano, Italy|UO Ematologia - AOU Policlinico di Modena, Modena, Italy|S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy|Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2, Orbassano, Italy|Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy|Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy|S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy|Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia, Perugia, Italy|Div. di Ematologia di Muraglia - CTMO Ospedale San Salvator, Pesaro, Italy|U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy|Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, Piacenza, Italy|Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia, Pisa, Italy|Dipartimento Oncologico - Ospedale S.Maria delle Croci, Ravenna, Italy|Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|Ospedale "Infermi", Rimini, Italy|Complesso Ospedaliero S. Giovanni Addolorata, Roma, Italy|S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy|U.O.C. Ematologia - Ospedale S.Eugenio, Roma, Italy|Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy|Università degli Studi - Policlinico di Tor Vergata, Roma, Italy|UOC di Ematologia e Trapianti di Cellule Staminali Emopoietiche - AOU San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy|U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte", Siena, Italy|Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy|Azienda U.L.S.S.9 - U.O. di Ematologia, Treviso, Italy|Clinica Ematologica - Policlinico Universitario, Udine, Italy|Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi, Verona, Italy|ULSS N.6 Osp. S. Bortolo, Vicenza, Italy Less << |
NCT01650805 | Chronic Myeloid Leukemia | Phase 3 | Terminated(Study terminated ba... More >>sed on evaluation of safety data.) Less << | - | - |
NCT03589326 | Lymphoblastic Leukemia, Acute,... More >> Adult Acute Lymphoid Leukemia Leukemia, Acute Lymphoblastic Leukemia, Lymphoblastic Ph1 Chromosome Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Less << | Phase 3 | Recruiting | July 4, 2026 | United States, California ... More >> City of Hope - Duarte Recruiting Duarte, California, United States, 91010 United States, South Carolina Saint Francis Cancer Center Recruiting Greenville, South Carolina, United States, 29607 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4000 Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 Less << |
NCT02265341 | Malignant Hepatobiliary Neopla... More >>sm Less << | Phase 2 | Active, not recruiting | October 15, 2019 | United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less << |
NCT02467270 | Myeloid Leukemia, Chronic, Chr... More >>onic Phase Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-03-31 | Emory University Winship Cance... More >>r Institute, Atlanta, Georgia, 30322, United States|Indiana Blood & Marrow Transplantation, Indianapolis, Indiana, 46237, United States|University of Maryland Medical Center, Baltimore, Maryland, 21201, United States|Michigan Medicine, Ann Arbor, Michigan, 48109, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|University of Minnesota Medical School, Minneapolis, Minnesota, 55455, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Memorial Sloan-Kettering Cancer Center - New York, New York, New York, 10065, United States|NewYork-Presbyterian Weill Cornell Medical Center, New York, New York, 10065, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Cleveland Clinic Taussig Cancer Institute Main Campus, Cleveland, Ohio, 44195, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|Fundaleu, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1114AAN, Argentina|Hospital General de Agudo Jose Maria Ramos Mejia, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1221ADC, Argentina|Hospital Italiano La Plata, La Plata, Buenos Aires, B1900AXI, Argentina|Royal North Shore Hospital, Saint Leonards, New South Wales, 2065, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Princess Margaret Hospital - Toronto, Toronto, Ontario, M5G 2M9, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|Saskatchewan Cancer Agency, Regina, Saskatchewan, S4T 7T1, Canada|Hospital del Salvador, Providencia, Santiago, 7500922, Chile|Centro de Investigaciones Clinicas Vina del Mar, Vina del Mar, Valparaiso, 2540364, Chile|Ustav Hematologie a Krevni Transfuze Praha, Prague, Praha, 12820, Czechia|Fakultni Nemocnice Olomouc, Olomouc, 772 00, Czechia|Aarhus University Hospital, Aarhus C, \Aarhus, DK-8000, Denmark|Centre de Lutte Contre le Cancer - Institut Bergonie, Bordeaux, Aquitaine, 33076, France|Centre Hospitalier Universitaire de Nancy Hopital de Brabois, Vandoeuvre les Nancy, Lorraine, 54511, France|Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse Cedex 9, Midi-pyrenees, 31059, France|Centre Hospitalier Regional Universitaire de Lille, Lille cedex, NORD Pas-de-calais, 59037, France|Center Hospitalier Universitaire d'Angers, Angers Cedex 9, PAYS DE LA Loire, 49933, France|Centre Hospitalier Universitaire de Nantes Hotel Dieu, Nantes Cedex 1, PAYS DE LA Loire, 44093, France|Centre Hospitalier Universitaire de Poitiers, Poitiers Cedex, Poitou-charentes, 86021, France|Centre Hospitalier Universitaire de Nice Hopital l'Archet, Nice Cedex 3, Provence Alpes COTE D'azur, 06202, France|Universitaetsklinikum Heidelberg, Mannheim, Baden-wuerttemberg, 68169, Germany|Universitatsklinikum Ulm, Ulm, Baden-wuerttemberg, 89081, Germany|Universitatsmedizin Rostock, Rostock, Mecklenburg-vorpommern, 18057, Germany|Uniklinik RWTH Aachen, Aachen, Nordrhein-westfalen, 52074, Germany|Universitaetsklinikum Essen, Essen, Nordrhein-westfalen, 45147, Germany|Universitatsklinikum Jena, Jena, Thuringen, 07747, Germany|Charite Universitatsmedizin Berlin, Berlin, 13353, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Queen Mary Hospital, Hong Kong, 852, Hong Kong|Azienda Ospedaliera San Gerardo di Monza, Monza, Monza E Brianza, 20090, Italy|Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Pesaro E Urbino, 61100, Italy|Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele, Catania, 95124, Italy|Azienda Ospedaliera Universitaria San Martino, Genova, 16132, Italy|Azienda Sanitaria Locale di Pescara Ospedale Civile Dello Spirito Santo, Pescara, 65124, Italy|Sapienza Universita Di Roma, Roma, 00161, Italy|AOUI - Ospedale Policlinico "Giambattista Rossi" di Borgo Roma, Verona, 37134, Italy|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, 6591, Korea, Republic of|Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu, Wroclaw, Dolnoslaskie, 50-367, Poland|Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz, Lodzkie, 93-510, Poland|Malopolskie Centrum Medyczne, Krakow, Malopolskie, 30-510, Poland|Instytut Hematologii i Transfuzjologii, Warszawa, Mazowieckie, 02-776, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, Pomorskie, 80-952, Poland|Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisboa, 1090-023, Portugal|Centro Hospitalar Sao Joao, Porto, 4200-319, Portugal|Rostov State Medical University, Rostov-na-Donu, Rostov, 344022, Russian Federation|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, 454076, Russian Federation|Kemerovo Regional Clinical Hospital, Kemerovo, 650066, Russian Federation|GBUZ Moscow Clinical Scientific Center DZM, Moscow, 111123, Russian Federation|Russian Academy of Medical Science, Moscow, 125167, Russian Federation|FGU Russian Scientific Research Institute of Hematology and Transfusiology, Saint Petersburg, 191024, Russian Federation|Almazov Federal North-West Medical Research Centre of Department of Health of Russian Federation, Saint Petersburg, 197341, Russian Federation|Samara State Medical University, Samara, 443099, Russian Federation|Saratov State Medical University, Saratov, 355018, Russian Federation|Singapore General Hospital, Singapore, 169856, Singapore|Hospital Regional Universitario Carlos Haya, Malaga, Andalucia, 29010, Spain|Hospital Universitario de Gran Canaria Doctor Nergrin, Las Palmas de Gran Canaria, LAS Palmas, 35010, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, 08036, Spain|Hospital Universitario de La Princesa, Madrid, 28006, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Akademiska Sjukhuset, Uppsala, 751 85, Sweden|University Hospital Zurich, Zurich, 8091, Switzerland|National Taiwan University Hospital, Taipei, 100, Taiwan|Royal Liverpool University Hospital NHS Trust, Liverpool, England, L7 8XP, United Kingdom|King's College Hospital NHS Foundation Trust, London, England, SE5 9RS, United Kingdom|Imperial College Healthcare NHS Trust, London, England, W12 0NN, United Kingdom|Nottingham City Hospital NHS Trust, Nottingham, England, NG5 1PB, United Kingdom|Churchill Hospital, Oxford, England, OX3 7LE, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, G12 0YN, United Kingdom Less << |
NCT02981784 | - | Completed | - | France ... More >> Centre Hospitalier Lyon-Sud Pierre-Bénite, France, 69310 Less << | |
NCT02272998 | Malignant Neoplasm | Phase 2 | Recruiting | December 31, 2017 | United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ajjai Alva, MD 734-936-8906 Ajjai@med.umich.edu Principal Investigator: Ajjai Alva United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Sameek Roychowdhury, MD 614-685-5842 Sameek.Roychowdhury@osumc.edu Principal Investigator: Sameek Roychowdhury, MD Less << |
NCT03171389 | GIST, Malignant ... More >> KIT Exon 13 Mutation KIT Gene Mutation Less << | Phase 2 | Recruiting | September 22, 2020 | Germany ... More >> West German Cancer Center Recruiting Essen, NRW, Germany, 45122 Principal Investigator: Sebastian Bauer, Prof. Dr. Less << |
NCT03709017 | Chronic Myeloid Leukemia|Phila... More >>delphia Chromosome-positive Acute Lymphoblastic Leukemia Less << | UNKNOWN | 2025-06-23 | Kosin University Gaspel Hospit... More >>al, Busan, Korea, Republic of Less << | |
NCT02398825 | Chronic Myeloid Leukemia|Chron... More >>ic Phase|Adults Less << | PHASE2 | TERMINATED | 2022-12-27 | Aos Ss. Antonio E Biagio E C. ... More >>Arrigo - Soc Ematologia, Alessandria, Italy|Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi, Ancona, Italy|Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi, Bologna, 40138, Italy|Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy|Ao Brotzu, Presidio Ospedaliero A. Businco - Sc Ematologia E Ctmo, Cagliari, Italy|Ctc U.O Di Ematologia Con Trapianto Di Midollo Osseo, Catania, Italy|Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy|Ao Di Catanzaro "Pugliese-Ciaccio", Presidio Ospedaliero "Ciaccio - de Lellis" - Ematologia, Catanzaro, Italy|Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione, Cona, Italy|Aso S. Croce E Carle - Cuneo - Sc Ematologia, Cuneo, Italy|Irccs Aou San Martino - Genova - Uo Clinica Ematologica, Genova, Italy|Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy|.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy|Aou Policlinico "G. Martino" - Messina - Uoc Ematologia, Messina, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy|Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia, Milano, Italy|Milano Unità Trapianto di Midollo Ist. Nazionale Tumori, Milano, Italy|Ao Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Ematologia Con Trapianto Di Midollo, Napoli, Italy|Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy|Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy|Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy|Aou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy|Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy|Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy|Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto, Piacenza, Italy|Aou Pisana - Uo Ematologia Universitaria, Pisa, Italy|Ausl Della Romagna, Ospedale "Santa Maria Delle Croci" - Ravenna - Ematologia, Ravenna, Italy|Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy|Ao San Camillo Forlanini - Roma - Uoc Ematologia E Trapianto Cellule Staminali, Roma, Italy|Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia, Roma, Italy|Roma Uoc Pronto Soccorso E Accettazione Ematologica - Dipartimento Biotecnologie Cellulari Ed Ematologia - Università Degli Studi Di Roma "Sapienza", Roma, Italy|Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy|Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy|Ao S. Maria - Terni - Sc Onco Ematologia, Terni, Italy|Unità Operativa Di Ematologia - Presidio Ospedaliero Di Treviso - Azienda Ulss N.2 Marca Trevigiana, Treviso, Italy|Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia, Verona, Italy|Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia, Vicenza, Italy Less << |
NCT02829840 | Leukemia FLT3... More >>-Mutated Acute Myeloid Leukemia FLT3-Mutated High-Risk Myelodysplastic Syndrome Less << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT01667133 | Chronic Myeloid Leukemia (CML)... More >> Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Less << | Phase 1 Phase 2 | Completed | - | Japan ... More >> Aichi Cancer Center Hospital Nagoya-shi, Aichi, Japan, 464-8681 Akita University Hospital Akita-shi, Akita, Japan, 010-8543 Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Hiroshima-shi, Hiroshima, Japan, 730-8619 Kyushu University Hospital Hukuoka-shi, Hukuoka, Japan Kinki University Hospital, Faculty of Medicine Osakasayama-shi, Osaka, Japan, 589-8511 The Cancer Institute Hospital Japanese Foundation for Cancer Research Koto, Tokyo, Japan The University of Tokyo, The Institute of Medical Science Minato-ku, Tokyo, Japan Keio University Hospital Shinjuku-ku, Tokyo, Japan Osaka City University Hospital Shinjuku-ku, Tokyo, Japan National Cancer Center Hospital Chuo-ku, Tokyo, Japan Tokyo Medical University Hospital Shinjuku-ku, Tokyo, Japan Less << |
NCT01874665 | GIST | PHASE2 | COMPLETED | 2016-07-31 | Massachusetts General Hospital... More >>, Site #047, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Site #008, Boston, Massachusetts, 02215, United States|Oregon Health & Sciences University, Site #048, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Site #012, Philadelphia, Pennsylvania, 19111, United States Less << |
NCT01874665 | GIST | PHASE2 | COMPLETED | 2016-07-31 | Massachusetts General Hospital... More >>, Site #047, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Site #008, Boston, Massachusetts, 02215, United States|Oregon Health & Sciences University, Site #048, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Site #012, Philadelphia, Pennsylvania, 19111, United States Less << |
NCT02478164 | Glioblastoma | PHASE2 | COMPLETED | 2018-05-09 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less << |
NCT02478164 | Glioblastoma | PHASE2 | COMPLETED | 2018-05-09 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less << |
NCT03690115 | Leukemia, Myeloid, Acute | Phase 2 | Not yet recruiting | May 2022 | France ... More >> CHU NAgers Not yet recruiting Angers, France Contact: François CHu Brest Not yet recruiting Brest, France Contact: Guillerm CHU Caen Not yet recruiting Caen, France Contact: Chantepie CHU Clermont Ferrand Not yet recruiting Clermont Ferrand, France Contact: Guieze CHU Grenoble Not yet recruiting Grenoble, France Contact: Bulabois CHU Lille Not yet recruiting Lille, France Contact: Yakoub Agha CHU Limoges Not yet recruiting Limoges, France Contact: Turlure Chevallier Not yet recruiting Nantes, France Contact: Patrice Chevallier Hopital St Antoine Not yet recruiting Paris, France Contact: Mothy Hopital St Louis Not yet recruiting Paris, France Contact: Regis Peffault de la tour CHu Lyon Not yet recruiting Pierre-Bénite, France Contact: Labussière CHU Poitiers Not yet recruiting Poitiers, France Contact: Maillard CRLC Toulouse Not yet recruiting Toulouse, France Contact: Huynh CHU Nancy Not yet recruiting Vandœuvre-lès-Nancy, France Contact: Rubio Less << |
NCT01592136 | - | - | - | - | |
NCT02627677 | Chronic Phase Chronic Myeloid ... More >>Leukemia Less << | Phase 3 | Active, not recruiting | December 31, 2022 | Belgium ... More >> Cliniques Universitaire Saint-Luc (Site 058) Bruxelles, Belgium, 1200 Less << |
NCT01813734 | Non Small Cell Lung Cancer | PHASE2 | COMPLETED | 2025-08-18 | University of California, Irvi... More >>ne, Orange, California, 92868, United States|University of Maryland, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, 02115, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Ohio State University, Columbus, Ohio, 43210, United States Less << |
NCT01570868 | Leukemia | PHASE2 | TERMINATED | 2025-05-16 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
NCT01935336 | Adenocarcinoma of the Lung|Ext... More >>ensive Stage Small Cell Lung Cancer|Limited Stage Small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer Less << | PHASE2 | COMPLETED | 2025-11-17 | University of Colorado Cancer ... More >>Center, Aurora, Colorado, 80045, United States Less << |
NCT01761747 | - | Terminated(FDA hold and toxici... More >>ty associated with study drug) Less << | - | - | |
NCT01888562 | Endometrial Neoplasms | WITHDRAWN | 2025-07-23 | - | |
NCT02428543 | Acute Myeloid Lukemia | Phase 1 Phase 2 | Recruiting | September 2020 | France ... More >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB achaib@ch-aix.fr Principal Investigator: Abdelaziz CHAIB Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre Principal Investigator: MAROLLEAU Jean Pierre CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS Magardembas@chu-angers.fr Principal Investigator: Martine GARDEMBAS Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad ahmad.aljijakli@ch-argenteuil.fr Principal Investigator: AL JIJAKLI Ahmad Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA erandiamalala@ch-cotebasque.fr Principal Investigator: Edouard RANDIAMALALA CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA flarosa@chu-besançon.fr Principal Investigator: Fabrice LAROSA Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN thorsten.braun@aphp.fr Principal Investigator: Thorsten BRAUN CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra b.choufi@ch-boulogne.fr Principal Investigator: CHOUFI Bachra Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly reman-o@chu-caen.fr Principal Investigator: REMAN Oumédaly Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON jvmalf@free.fr Principal Investigator: Jean Valère MALFUSSON Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT Principal Investigator: Stéphanie HAÏAT Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile cecile.pautas@hmn.aphp.fr Principal Investigator: PAUTAS Cécile CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis denis.caillot@chu-dijon.fr Principal Investigator: CAILLOT Denis Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe 003339638622 phrousselot@ch-versailles.fr Principal Investigator: Rousselot Philippe Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno bquesnel@chru-lille.fr Principal Investigator: QUESNEL Bruno CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal pascal.turlure@chu-limoges.fr Principal Investigator: TURLURE Pascal Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier xavier.thomas@chu-lyon.fr Principal Investigator: THOMAS Xavier Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO regis.costello@ap-hm.fr Principal Investigator: Regis COSTELLO Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé j-frayfer@ch-meaux.fr Principal Investigator: FRAYFER Jamilé Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE ojedam@ch-mulhouse.fr Principal Investigator: Mario OJEDA-URIBE Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY jacques.delaunay@chu-nantes.fr Principal Investigator: Jacques DELAUNAY CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel mannone.l@chu-nice.fr Principal Investigator: MANNONE Lionel CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN eric.jourdan@chu-nimes.fr Principal Investigator: Eric Jourdan Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise francoise.isnard@sat.aphp.fr Principal Investigator: ISNARD Françoise Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe felipe.suarez@nck.aphp.fr Principal Investigator: SUAREZ Felipe Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel emmanuel.raffoux@sls.ap-hop-paris.fr Principal Investigator: RAFFOUX Emmanuel Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina madalina.uzunov@psl.aphp.fr Principal Investigator: UZUNOV Madalina Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX arnaud.pigneux@chu-bordeaux.fr Principal Investigator: Arnaud PIGNEUX Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana ioana.vaida@ch-pontoise.fr Principal Investigator: VAIDA Iona Dana Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD marc.bernard@chu-rennes.fr Principal Investigator: Marc BERNARD Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE emilie.lemasle@chb.unicancer.fr Principal Investigator: Emilie LEMASLE Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY emmanuelle.tavernier@icloire.fr Principal Investigator: Emmanuelle TAVERNIER-TARDY Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI Principal Investigator: Réda GARIDI Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER Principal Investigator: Christian RECHER Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José fernandes-j@ch-valenciennes.fr Principal Investigator: FERNANDES José Less << |
NCT01761747 | Non-Small Cell Lung Cancer, He... More >>ad and Neck Cancer Less << | Phase 2 Phase 3 | Terminated(FDA hold and toxici... More >>ty associated with study drug) Less << | - | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less << |
NCT04043676 | Chronic Myeloid Leukemia | PHASE2 | UNKNOWN | 2023-04-30 | Hospital Trials i Pujol, Badal... More >>ona, Barcelona, 08916, Spain|Hospital Vall D'Hebron, Barcelona, 08035, Spain|Hospital Universitario de Gran Canarias Dr. Negrin, Las Palmas De Gran Canaria, 35010, Spain|Hospital Unversitario de la Princesa, Madrid, 28006, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario Doce de Octubre, Madrid, 28041, Spain|Hospital Regional de Malaga, Málaga, 29010, Spain|Hospital Universitario de Salamanca, Salamanca, 37007, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain Less << |
NCT03838692 | Medullary Thyroid Cancer | PHASE2 | WITHDRAWN | 2021-06-14 | - |
NCT03934372 | Acute Myeloid Leukemia|Acceler... More >>ated Phase Chronic Myeloid Leukemia|Blast Phase Chronic Myeloid Leukemia|Chronic Phase Chronic Myeloid Leukemia|Acute Lymphoblastic Leukemia|Acute Lymphocytic Leukemia|Leukemia|Lymphoma|Solid Tumors Less << | PHASE1|PHASE2 | RECRUITING | 2026-01-30 | Ghent University Hospital, Ghe... More >>nt, 09000, Belgium|Universitair Ziekenhuis (Uz) Leuven, Leuven, 03000, Belgium|The Finsen Centre National Hospital, Copenhagen, 02100, Denmark|Hopital Robert Debre, Paris, 75019, France|Armand Trousseau Hospital, Paris, 75571, France|Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France|Chu de Rennes - Hospital Sud, Rennes, 35700, France|Universitaetsklinikum Erlangen - Medizinische Klinik 5, Erlangen, 91054, Germany|Universitatsklinikum Essen, Essen, 45147, Germany|Aou Policlinico S. Orsola-Malpighi Bologna, Bologna, 40138, Italy|Asst Degli Spedali Civili Di Brescia, Brescia, 25123, Italy|Ospedale Pediatrico G. Gaslini, Genova, 16147, Italy|Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, Milan, 20133, Italy|Ospedale San Gerardo - Asst Monza, Monza, 20900, Italy|University of Milano Bicocca, Monza, 20900, Italy|Aorn Santobono Pausilipon, Naples, 80122, Italy|Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo, Pavia, 27100, Italy|Ospedale Pediatrico Bambino Gesu Irccs, Rome, 00165, Italy|A.O.U Citta Della Salute E Della Scienza Di Torino Presidio Ospedaliero Infantile Regina Margherita, Torino, 10126, Italy|Princess Maxima Center For Pediatric Oncology, Utrecht, 03584, Netherlands|Hospital General Universitario Vall D Hebron, Barcelona, 08035, Spain|Hospital Sant Joan de Deu de Manresa, Barcelona, 08035, Spain|Hospital Infantil Unversitario Nino Jesus, Madrid, 28009, Spain|Hospital Universitario de La Paz, Madrid, 28046, Spain|Hospital Universitari I Politecnic La Fe, Valencia, 46026, Spain|Karolinska Universitetssjukhuset Solna, Solna, 171 76, Sweden|Karolinska University Hospital Solna, Stockholm, 14141, Sweden|University Hospital Birmingham, Birmingham, B15 2TH, United Kingdom|Royal Hospital For Sick Children Yorkhill Glasgow, Glasgow, G514TF, United Kingdom|Alder Hey Childrens Nhs Foundation Trust, Liverpool, L12 2AP, United Kingdom|The Royal Marsden Nhs Foundation Trust - Sutton, Sutton, SM2 5PT, United Kingdom|The Royal Marsden NHS Foundation Trust, Sutton, SW3 6JJ, United Kingdom Less << |
NCT04475731 | Philadelphia-Positive ALL|Acut... More >>e Lymphoblastic Leukemia, in Relapse Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-11-24 | Aou Ospedali Riuniti "Umberto ... More >>I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy|Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia, Ascoli Piceno, Italy|Ao Di Rilievo Nazionale E Di Alta Specialità "San Giuseppe Moscati" - Avellino - Uoc Ematologia Con Unità Di Trapianto, Avellino, Italy|Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, Bari, Italy|Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy|Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy|Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy|Aso S. Croce E Carle - Cuneo - Sc Ematologia, Cuneo, Italy|Aou Careggi - Firenze - Sod Ematologia, Firenze, Italy|Aou Policlinico "G. Martino" - Messina - Uoc Ematologia, Messina, Italy|Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy|Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy|Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia, Milano, Italy|Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy|Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy|Ao Ospedali Riuniti Marche Nord - Ospedale San Salvatore - Pesaro - Uoc Ematologia E Centro Trapianti, Pesaro, Italy|Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia, Roma, Italy|Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche, Salerno, Italy|Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy|Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy|Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy|Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia, Verona, Italy Less << |
NCT05306301 | Chemotherapy|Leukemia, Acute L... More >>ymphoblastic Less << | PHASE2 | RECRUITING | 2028-07-01 | Ematologia con Unità di Trapia... More >>nto, Avellino, AV, 83100, Italy|Ematologia Presidio Ospedaliero Tortora, Pagani, SA, Italy|Ematologia ASST Papa Giovanni XXIII, Bergamo, Italy|Ematologia AOU S.ORSOLA-MALPIGHI, Bologna, Italy|Ematologia ASST Spedali Civili, Brescia, Italy|Ematologia AOU Policlinico Vittorio Emanuele-Ferrarotto, Catania, Italy|Ematologia AOU Careggi, Firenze, Italy|Ematologia Ospedale V.Fazzi, Lecce, Italy|Ematologia Ospedale dell'Angelo, Mestre, Italy|Ematologia Ospedale Maggiore Policlinico, Milano, Italy|Ematologia AOU Federico II, Napoli, Italy|Ematologia AOU Maggiore della Carità, Novara, Italy|Ematologia AO Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy|Ematologia Fondazione Policlinico San Matteo, Pavia, Italy|Ematologia Presidio Ospedaliero Spirito Santo, Pescara, Italy|Ematologi Presidio Ospedaliero Guglielmo da Saliceto, Piacenza, Italy|Ematologia Presidio Ospedaliero Infermi, Rimini, Italy|Dipartimento di Medicina Traslazionale e di Precisione - Ematologia, Roma, Italy|Ematologia AOU Policlinico Tor Vergata, Roma, Italy|Ematologia Policlinico A.Gemelli, Roma, Italy|Ematologia AOU Senese, Siena, Italy|Ematologia Ospedale Mauriziano, Torino, Italy|Ematologia Ospedale S.Giovanni Battista Molinette, Torino, Italy|Ematologia Policlinico G.B. Rossi, Verona, Italy Less << |
NCT04233346 | Chronic Myeloid Leukemia|Acute... More >> Lymphoblastic Leukemia Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-12-31 | Anhui Provincial Hospital, Hef... More >>ei, Anhui, China|The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China|Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China|Xiangya Hospital Central South University, Changsha, Hunan, China|The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China|Shengjing Hospital of China Medical University, Shenyang, Liaoning, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Second hospital of Shanxi Medical University, Taiyuan, Shanxi, China|Shenzhen Second People's Hospital, Shenzhen, Shenzhen, China|West China Hospital, Sichuan University, Chengdu, Sichuan, China|The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, China|1st affiliated hospital, Peking University, Beijing, China|Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, China Less << |
NCT03807479 | Leukemia, Myeloid, Chronic-Pha... More >>se Less << | PHASE2 | TERMINATED | 2023-08-31 | University Hospital, Halle (Sa... More >>ale), Saxony-Anhalt, 06097, Germany|University Hospital RWTH Aachen,Clinic for Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Department IV, Aachen, 52074, Germany|Charité University Medicine Berlin - Medical Clinic, Department of Hematology, Oncology and Tumor Immunology, Berlin, 13353, Germany|University Hospital Essen gGmbH, Westdeutsches Tumorzentrum; Internal Medicine (Tumor Research), Essen, 45122, Germany|University Medicine Greifswald, Clinic and Policlinic - Internal Medicine C - Hematology and Oncology, Greifswald, 17475, Germany|Asklepios Clinic St. Georg - Department of Oncology, Section Hematology, Hamburg, 20099, Germany|University Hospital Mannheim GmbH, III. Medical Clinic for Hematology and Oncology, Mannheim, 68167, Germany|Clinic for Hematologie, Marburg, 35043, Germany|UKRUB University Hospital of Ruhr-University Bochum, Clinic for Hematology and Oncology, Minden, 32429, Germany|University Hospital Ulm - Department for internal medicine III, Ulm, 89081, Germany Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.88mL 0.38mL 0.19mL |
9.39mL 1.88mL 0.94mL |
18.78mL 3.76mL 1.88mL |